Nineteen human breast tumours were analysed for c-erbβ-2 gene amplification, the over-expression of its mRNA and the production of its protein residue by southern blot, northern blot and western blot techniques respectively. Protein expression was also assessed by immunohistochemistry on paraffin sections. c-erbβ-2 gene amplification was found in 6 of 19 (31%) tumours. Over-expression of c-erbβ-2 mRNA was found in 7 of 19 (37%) tumours. Expression of the 185 kd c-erbβ-2 protein product was detected in 3 of 19 (16%) tumours by western blotting and in 5 of 19 (26%) by immunohistochemistry. In only 4 tumours with an amplified c-erbβ-2 gene was there a clear association between all three parameters. In view of the conflicting reports in the literature concerning c-erbβ-2 gene amplification or protein over-expression (assessed by western blot or immunohistochemistry) and prognosis of breast cancer, studies in which these parameters are correlated individually with prognosis in the same group of patients are needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.